æz ɐ kˈɑːnsɪkwəns, pˈɪɾɐvˌæstɐtˌɪn ɪz lˈaɪkli təbi ɐpɹˈoʊpɹɪət fɔːɹ pˈeɪʃənts wɪð mˌɛɾəbˈɑːlɪk sˈɪndɹoʊm plˈʌs hˈaɪ ˌɛldˌiːˈɛl, lˈoʊ ˌeɪtʃdˌiːˈɛl ænd dˌaɪəbˈiːɾiːz mˈɛlɪɾəs.
As a consequence, pitavastatin is likely to be appropriate for patients with metabolic syndrome plus high LDL, low HDL and diabetes mellitus.